FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055245 [Registered on: 14/07/2023] Trial Registered Prospectively
Last Modified On: 08/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   To evaluate the efficacy of Tilvakadi paste application and tilvakadi eyedrop instillation in the management of burning sensation in eyes  
Scientific Title of Study   AN OPEN LABELLED RANDOMISED CONTROLLED CLINICAL TRIAL OF TILVAKADI PINDI AND TILVAKADI EYE DROP IN PITTAJ ABHISHYANDA 
Trial Acronym  An open labelled randomised controlled clinical trial of Tilvakadi Pindi AND Tilvakadi Eyedrop in Pittaj Abhishyanda 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shivkant Sharma  
Designation  Associate Professor 
Affiliation  Parul Institute of Ayurved 
Address  OPD-108, Parul Ayurveda Hospital, Shalakya tantra department, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, VADODARA, Gujarat

Vadodara
GUJARAT
391760
India 
Phone  8847864068  
Fax    
Email  shivkants@ymail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Surabhi Khare  
Designation  PG Scholar  
Affiliation  Parul Institute of Ayurved 
Address  OPD-108,Parul Ayurveda Hospital, Shalakya tantra department, Parul institute of Ayurved, Parul University, At Post-Limda, Tal- Waghodia, VADODARA, Gujarat 391760

Vadodara
GUJARAT
391760
India 
Phone  7880112800  
Fax    
Email  kharesurbhi11@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Surabhi Khare 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved 
Address  OPD-108,Parul Ayurveda Hospital, Shalakya tantra department, Parul institute of Ayurved, Parul University, At Post-Limda, Tal- Waghodia, VADODARA, Gujarat 391760

Vadodara
GUJARAT
391760
India 
Phone  7880112800  
Fax    
Email  kharesurbhi11@gmail.com  
 
Source of Monetary or Material Support  
Parul Ayurved Hospital, Parul Institute of Ayurved, Parul university, Vadodara Gujarat 
 
Primary Sponsor  
Name  Dean Parul Institute of Ayurved  
Address  Parul Ayurved hospital, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, VADODARA, Gujarat. 391760  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Surabhi Khare  Parul Institute of Ayurved  OPD-108,Parul Ayurveda hospital, Shalakya tantra department, Parul institute of Ayurveda, Parul University, At Post-Limda, Tal- Waghodia, VADODARA, Gujarat. 391760
Vadodara
GUJARAT 
7880112800

kharesurbhi11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H103||Unspecified acute conjunctivitis. Ayurveda Condition: PITTABISHYANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Tilvakadi Eyedrops , Reference: Yogaratnakara Samhita, Netraroga Chikitsa, Shloka number 370, Route: Topical, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 2(drops), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmProcedure-piNDI, पिण्डी (Procedure Reference: Sarangadhara samhita, Uttara khanda, Chapter 13, Shloka number 21, Procedure details: Take powder of Raktachandana, Madhuka, Lodhra, Jatipushpa and Gairika in equal proportion and mixed with water to form a paste and kept in a thin cotton cloth used as a Pindi for local application.)
(1) Medicine Name: Tilvakadi Pindi, Reference: Yogaratnakara Samhita, Netraroga Chikitsa, Shloka number 370, Route: Ocular, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Duration: 7 Days
3Comparator ArmProcedure-piNDI, पिण्डी (Procedure Reference: Sarangadhara samhita, Uttara khanda, Chapter 13, Procedure details: Take the powder of Amalaki fruit (Emblica officinalis) mixed with water to form a paste and kept in a thin cotton cloth used as a Pindi for local application. )
(1) Medicine Name: Amalaki Pindi, Reference: Sarangadhara samhita, Uttara khanda, Chapter 13, Shloka number 26, Route: Ocular, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients of age group between 18 to 50 years of age.
Patients presenting with signs and symptoms of Pittaj Abhishyanda.

Patient’s irrespective of gender, caste, socioeconomic status etc.
 
 
ExclusionCriteria 
Details  Patients having complication like marginal corneal ulcer, trachoma, dacryocystitis, infective conjunctivitis etc.

Patient with concurrent serious systemic illness like diabetes mellitus, hypertension, hepatitis etc.

Patient who are not willing for trial.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Patient will get relief from symptoms like burning sensation and watering from eyes  0th day, 8th day, 15th day 
 
Secondary Outcome  
Outcome  TimePoints 
Patient will get relief from symptoms like foreign body sensation, photophobia and redness in eyes   0th day, 8th day, 15th day 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   16/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

These days, eye problems are most frequently seen due to a variety of etiological factors.

The protection of the eye is given significant priority in all areas of research because it is one of the primary sense organs.

Pittaj Abhishyanda is frequently seen in our OPD on a routine basis. Because of direct exposure to heat, cold, sunlight, dust particle and etc. It happens rather often.

In view of the magnitude of the disease the discomfort it causes to the patients and cost of the treatment, there is need to develop a therapy which is free from side effect, cheaper and has a significant effect in reduce the symptoms of the patient.

Many patients are unable to visit the hospital for a fairly straightforward procedure due to a fast-paced lifestyle, hectic working hours, as well as other unavoidable factors.

We have tried to transform the Pindi Kriyakalpa into an eyedrops in order to get over these challenges and make ayurvedic procedures more patient-friendly. So instead of changing the drug, we alter the form of medicine. When compared to Pindi, using eyedrops saves time.

 
Close